Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

2.

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia.

Burack MA, Hartlein J, Flores HP, Taylor-Reinwald L, Perlmutter JS, Cairns NJ.

Neurology. 2010 Jan 5;74(1):77-84. doi: 10.1212/WNL.0b013e3181c7da8e.

3.

Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report.

Cairns NJ, Ikonomovic MD, Benzinger T, Storandt M, Fagan AM, Shah AR, Reinwald LT, Carter D, Felton A, Holtzman DM, Mintun MA, Klunk WE, Morris JC.

Arch Neurol. 2009 Dec;66(12):1557-62. doi: 10.1001/archneurol.2009.279.

4.

Comparison of 18F-FDG and PiB PET in cognitive impairment.

Lowe VJ, Kemp BJ, Jack CR Jr, Senjem M, Weigand S, Shiung M, Smith G, Knopman D, Boeve B, Mullan B, Petersen RC.

J Nucl Med. 2009 Jun;50(6):878-86. doi: 10.2967/jnumed.108.058529. Epub 2009 May 14.

5.

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.

Price JL, McKeel DW Jr, Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, Smith CD, Davis DG, Schmitt FA, Markesbery WR, Kaye J, Kurlan R, Hulette C, Kurland BF, Higdon R, Kukull W, Morris JC.

Neurobiol Aging. 2009 Jul;30(7):1026-36. doi: 10.1016/j.neurobiolaging.2009.04.002. Epub 2009 Apr 18.

6.

Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics.

Maetzler W, Liepelt I, Reimold M, Reischl G, Solbach C, Becker C, Schulte C, Leyhe T, Keller S, Melms A, Gasser T, Berg D.

Neurobiol Dis. 2009 Apr;34(1):107-12. doi: 10.1016/j.nbd.2008.12.008. Epub 2008 Dec 31.

PMID:
19162186
7.

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.

Edison P, Rowe CC, Rinne JO, Ng S, Ahmed I, Kemppainen N, Villemagne VL, O'Keefe G, Någren K, Chaudhury KR, Masters CL, Brooks DJ.

J Neurol Neurosurg Psychiatry. 2008 Dec;79(12):1331-8. doi: 10.1136/jnnp.2007.127878. Epub 2008 Jul 24.

PMID:
18653550
8.

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.

Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, Debnath ML, Hope CE, Isanski BA, Hamilton RL, DeKosky ST.

Brain. 2008 Jun;131(Pt 6):1630-45. doi: 10.1093/brain/awn016. Epub 2008 Mar 12.

9.

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.

Jack CR Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, Knopman DS, Boeve BF, Klunk WE, Mathis CA, Petersen RC.

Brain. 2008 Mar;131(Pt 3):665-80. doi: 10.1093/brain/awm336. Epub 2008 Feb 7.

10.

[11C]PIB binding in Parkinson's disease dementia.

Maetzler W, Reimold M, Liepelt I, Solbach C, Leyhe T, Schweitzer K, Eschweiler GW, Mittelbronn M, Gaenslen A, Uebele M, Reischl G, Gasser T, Machulla HJ, Bares R, Berg D.

Neuroimage. 2008 Feb 1;39(3):1027-33. Epub 2007 Oct 22.

PMID:
18035558
11.

In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.

Fodero-Tavoletti MT, Smith DP, McLean CA, Adlard PA, Barnham KJ, Foster LE, Leone L, Perez K, Cortés M, Culvenor JG, Li QX, Laughton KM, Rowe CC, Masters CL, Cappai R, Villemagne VL.

J Neurosci. 2007 Sep 26;27(39):10365-71.

12.

Mixed brain pathologies account for most dementia cases in community-dwelling older persons.

Schneider JA, Arvanitakis Z, Bang W, Bennett DA.

Neurology. 2007 Dec 11;69(24):2197-204. Epub 2007 Jun 13.

PMID:
17568013
13.

Imaging beta-amyloid burden in aging and dementia.

Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D, Smith C, Woodward M, Merory J, Tochon-Danguy H, O'Keefe G, Klunk WE, Mathis CA, Price JC, Masters CL, Villemagne VL.

Neurology. 2007 May 15;68(20):1718-25.

PMID:
17502554
14.

Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report.

Bacskai BJ, Frosch MP, Freeman SH, Raymond SB, Augustinack JC, Johnson KA, Irizarry MC, Klunk WE, Mathis CA, Dekosky ST, Greenberg SM, Hyman BT, Growdon JH.

Arch Neurol. 2007 Mar;64(3):431-4.

PMID:
17353389
15.

Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease.

Ferman TJ, Smith GE, Boeve BF, Graff-Radford NR, Lucas JA, Knopman DS, Petersen RC, Ivnik RJ, Wszolek Z, Uitti R, Dickson DW.

Clin Neuropsychol. 2006 Dec;20(4):623-36.

PMID:
16980250
16.

The role of biomarkers in clinical trials for Alzheimer disease.

Thal LJ, Kantarci K, Reiman EM, Klunk WE, Weiner MW, Zetterberg H, Galasko D, Praticò D, Griffin S, Schenk D, Siemers E.

Alzheimer Dis Assoc Disord. 2006 Jan-Mar;20(1):6-15. Review.

17.

Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.

Lopresti BJ, Klunk WE, Mathis CA, Hoge JA, Ziolko SK, Lu X, Meltzer CC, Schimmel K, Tsopelas ND, DeKosky ST, Price JC.

J Nucl Med. 2005 Dec;46(12):1959-72.

18.

A systematic review of prevalence and incidence studies of dementia with Lewy bodies.

Zaccai J, McCracken C, Brayne C.

Age Ageing. 2005 Nov;34(6):561-6. Review.

19.

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M; Consortium on DLB.

Neurology. 2005 Dec 27;65(12):1863-72. Epub 2005 Oct 19. Review. Erratum in: Neurology. 2005 Dec 27;65(12):1992.

PMID:
16237129
20.

Unified segmentation.

Ashburner J, Friston KJ.

Neuroimage. 2005 Jul 1;26(3):839-51. Epub 2005 Apr 1.

PMID:
15955494
Items per page

Supplemental Content

Write to the Help Desk